Covidien Urges 1st Circ. To Reconsider Ex-Exec's Patent Win

Covidien LP has asked the full First Circuit to rehear a case that affirmed Covidien had no rights to three varicose vein treatment patents filed by a former top executive, arguing...

Already a subscriber? Click here to view full article